Novo Nordisk and Mylan Pharmaceuticals, now part of Viatris, have settled their patent dispute over Novo’s blockbuster ...

Liquidia’s stock $LQDA rose about 10% on Monday following a win in the US Supreme Court for its treprostinil inhalation ...

The news that Pfizer has an activist isn’t a surprise. For the last few months at Endpoints News, we’ve been asking which ...

Scholar Rock announced its experimental add-on treatment for spinal muscular atrophy significantly improved motor function ...

Want to lower drug prices? Good luck. In a new report released Friday, the nonpartisan Congressional Budget Office (CBO) detailed how many of the campaign proposals mentioned by presidential nominees ...

Dedicated to the memory of Natalie Grover, who co-created the Women in Biopharma R&D special report while she was a reporter ...

Global investment manager Oaktree is out with its third life sciences-dedicated special purpose acquisition company after ...

The activist investor Starboard Value has taken a stake in Pfizer, according to media reports, following the drugmaker's months of lackluster results as it came out of the pandemic and sought the next ...

The European Medicines Agency is looking more closely at medicines used to treat hair loss and a condition caused by an ...

Eli Lilly’s blockbuster GLP-1 drug tirzepatide is finally back on track in the US after two years of intermittent shortages ...

Enara Bio has snagged $32.5 million in a Series B fundraise, backed in part by Pfizer’s venture arm, to help develop a ...

Andrew Miller has quickly made his first move after the technology he invented, KarXT, secured an FDA approval last week. The ...